Euroespes S.A. - Asset Resilience Ratio

Latest as of December 2022: 8.53%

Euroespes S.A. (EEP) has an Asset Resilience Ratio of 8.53% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check EEP PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€973.75K

≈ $1.14 Million USD Cash + Short-term Investments

Total Assets

€11.42 Million

≈ $13.35 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2024)

This chart shows how Euroespes S.A.'s Asset Resilience Ratio has changed over time. See EEP net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Euroespes S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see EEP company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€971.10K	8.5%
Short-term Investments	€2.65K	0.02%
Total Liquid Assets	€973.75K	8.53%

Asset Resilience Insights

Limited Liquidity: Euroespes S.A. maintains only 8.53% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Euroespes S.A. Industry Peers by Asset Resilience Ratio

Compare Euroespes S.A.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fleury S.A. SA:FLRY3	Diagnostics & Research	16.06%
Wuhan Thalys Med Tech Co Ltd SHG:603716	Diagnostics & Research	0.12%
Spectral Med Inc TO:EDT	Diagnostics & Research	11.67%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Genetic Signatures Ltd AU:GSS	Diagnostics & Research	60.91%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Euroespes S.A. (2010–2024)

The table below shows the annual Asset Resilience Ratio data for Euroespes S.A..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.01%	€370.00 ≈ $432.57	€6.94 Million ≈ $8.12 Million	-0.03pp
2023-12-31	0.03%	€2.47K ≈ $2.89K	€7.93 Million ≈ $9.27 Million	-8.50pp
2022-12-31	8.53%	€973.75K ≈ $1.14 Million	€11.42 Million ≈ $13.35 Million	-7.68pp
2021-12-31	16.21%	€1.99 Million ≈ $2.32 Million	€12.25 Million ≈ $14.32 Million	-2.95pp
2020-12-31	19.16%	€2.24 Million ≈ $2.62 Million	€11.70 Million ≈ $13.68 Million	+18.98pp
2019-12-31	0.18%	€20.46K ≈ $23.93K	€11.37 Million ≈ $13.30 Million	+0.05pp
2018-12-31	0.13%	€16.85K ≈ $19.70K	€12.76 Million ≈ $14.92 Million	-0.05pp
2017-12-31	0.18%	€16.76K ≈ $19.59K	€9.35 Million ≈ $10.93 Million	+0.17pp
2016-12-31	0.00%	€436.97 ≈ $510.86	€8.90 Million ≈ $10.40 Million	-0.06pp
2015-12-31	0.06%	€4.28K ≈ $5.00K	€6.73 Million ≈ $7.87 Million	-0.04pp
2014-12-31	0.10%	€6.38K ≈ $7.46K	€6.33 Million ≈ $7.41 Million	-1.79pp
2010-12-31	1.89%	€96.76K ≈ $113.12K	€5.11 Million ≈ $5.98 Million	--

pp = percentage points

About Euroespes S.A.

MC:EEP Spain Diagnostics & Research

Market Cap

$4.61 Million

€3.95 Million EUR

Market Cap Rank

#28993 Global

#212 in Spain

Share Price

€0.34

Change (1 day)

+0.00%

52-Week Range

€0.34 - €0.34

All Time High

€1.26